Financials
- Market Capitalization 14.15 B
- Employee 20 K
- Founded N/A
- CEO James C. Foster
- Website www.criver.com
- Headquarter Massachusetts, United States
- FIGI BBG000BG5BL8
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 662 | MEDP Medpace Holdings, Inc. - Common Stock | 611.57 USD | -1.21% | -0.42% | +7.13% | +0.82% | 17.07 B USD | ||
| 729 | RVTY Revvity, Inc. Common Stock | 129.67 USD | +2.61% | +4.57% | +16.40% | +36.70% | 14.47 B USD | ||
| 786 | ICLR ICON plc - Ordinary Shares | 169.72 USD | +0.47% | -1.91% | -5.71% | -3.27% | 13.00 B USD | ||
| 947 | TWST Twist Bioscience Corporation - Common Stock | 153.10 USD | +2.03% | +10.30% | +75.15% | +476.00% | 9.60 B USD |
Frequently asked questions about Charles River Laboratories International, Inc.
What is the Charles River Laboratories International, Inc. stock price today?
The current price of Charles River Laboratories International, Inc. (CRL) is 296.36. Over the past 24 hours, the stock has changed by +0.45%. Follow the CRL chart for real-time price dynamics.
What is the stock ticker of Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. trades under the ticker CRL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Charles River Laboratories International, Inc. stock going up?
CRL has changed by +1.70% over the last week, +23.60% over the last month, and +50.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. currently has a market capitalization of 14.15 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Charles River Laboratories International, Inc. earnings last quarter?
Last quarter, Charles River Laboratories International, Inc. reported earnings of -0.03 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Charles River Laboratories International, Inc. revenue for the last quarter?
Charles River Laboratories International, Inc. reported quarterly revenue of 1 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Charles River Laboratories International, Inc. net income for the last quarter?
Charles River Laboratories International, Inc. reported net income of -1.48 M for the last quarter. The previous quarter showed -14.84 M, which means net income changed by +90.02%.
How many employees does Charles River Laboratories International, Inc. have?
As of the latest available data, Charles River Laboratories International, Inc. has 19.7 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Charles River Laboratories International, Inc. EBITDA?
Charles River Laboratories International, Inc. EBITDA is 800.36 M, and its EBITDA margin is 79.71%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Charles River Laboratories International, Inc. stock?
You can buy Charles River Laboratories International, Inc. (CRL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Charles River Laboratories International, Inc. stock?
Investing in Charles River Laboratories International, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRL chart and related analysis on metatrader.com as part of your research.